In addition, the combination of urinary extracellular vesicle miR-145 and serum PSA improved the separation power between PCa and benign prostatic hyperplasia (BPH) over the use of PSA alone (AUC, 0.863 vs. 0.805). This evidence concerns the gene KLK3 and benign prostatic hyperplasia.